AVD chemotherapy

May 14, 2019

Health Canada Approves Adcetris-Chemo for Advanced Classical Hodgkin’s Lymphoma

News

Health Canada has approved Seattle Genetics‘ submission requesting approval of Adcetris (brentuximab vedotin) in combination with standard chemotherapy as a frontline treatment for patients with advanced (stage IV) classical Hodgkin’s lymphoma. ... Read more

September 21, 2018

Chemotherapy Used to Treat Hodgkin’s Lymphoma in Women Age 35 or Older Risks Damage to Ovaries, Study Finds

News

Damage to the ovaries is likely in women with Hodgkin’s lymphoma who are 35 years old or older and given standard chemotherapy, and in those at any age treated with BEACOPP chemotherapy, a secondary analysis ... Read more

September 11, 2018

Adcetris-Chemotherapy Combo Improves Survival Rates in Elderly Hodgkin’s Patients, Phase 2 Trial Shows

News

Adding Adcetris (brentuximab vedotin) to standard chemotherapy significantly improves responses and survival rates of elderly patients with newly diagnosed Hodgkin’s lymphoma, a Phase 2 study shows. In the trial, 90% of ... Read more